gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats

Neuroscience

Volumn 76, Issue 2, 1997, Pages 397-409

  Barks, J D E ^a   Liu, X H ^a   Sun, R ^a   Silverstein, F S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

AIDS; Excitatory amino acids; Glutamate antagonists; Newborn; NMDA

Indexed keywords

GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN INJURY; CONTROLLED STUDY; HIPPOCAMPUS; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALS; ANIMALS, NEWBORN; AUTORADIOGRAPHY; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; HIPPOCAMPUS; HIV ENVELOPE PROTEIN GP120; INJECTIONS; MALE; N-METHYLASPARTATE; NEUROTOXINS; PIPERAZINES; PYRROLIDINONES; QUISQUALIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0031015164     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00373-9     Document Type: Article

References (52)

1. Bagetta G., Corasaniti T. M., Finazzi-Agro A. and Nistico G. (1994) Does the HIV-1 coat protein gp120 produce brain damage? Trends. pharmac. Sci. 15, 362-363.
2. Barks J. D., Nair M. P., Schwartz S. A. and Silverstein F. S. (1993) Potentiation of N-methyl-D-aspartate-mediated brain injury by a human immunodeficiency virus-1-derived peptide in perinatal rodents. Pediatr. Res. 34, 192-198.
3. Barks J. D. E., Sun R., Malinak C. and Silverstein F. S. (1995) Gp120, an HIV-1 protein, increases susceptibility to hypoglycemic and ischemic brain injury in perinatal rats. Expl Neurol. 132, 123-133.
4. Belman A. L. (1992) Acquired immunodeficiency syndrome and the child's central nervous system. Pediatr. Clin. North Am. 39, 691-714.
5. + exchange in astrocytes. J. biol. Chem. 269, 13811-13816.
6. Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R. and Pert C. B. (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335, 639-642.
7. Corasaniti M. T., Melino G., Navarra M., Garaci E., Finazzi-Agrò A. and Nisticò G. (1995) Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase. Neurodegeneration 4, 315-321.
8. Dawson V. L., Dawson T. M., Uhl G. R. and Snyder S. H. (1993) Human immunodeficiency virus type-1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. natn. Acad. Sci. U.S.A. 90, 3256-3259.
9. Dickson D. W., Lee S. C., Mattiace L. A., Yen S. H. C. and Brosnan C. (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7, 75-83.
10. Epstein L. G. and Gendelman H. E. (1993) Human immunodeficiency virus type-1 infection of the nervous system - pathogenetic mechanisms. Ann. Neurol. 33, 429-436.
11. Giulian D., Wendt E., Vaca K. and Noonan C. A. (1993) The envelope glycoprotein of human immunodeficiency virus type-1 stimulates release of neurotoxins from monocytes. Proc. natn. Acad. Sci. U.S.A. 90, 2769-2773.
12. Glass J. D. and Johnson R. T. (1996) Human immunodeficiency virus and the brain. A. Rev. Neurosci. 19, 1-26.
13. Hill J. M., Mervis R. F., Avidor R., Moody T. W. and Brenneman D. E. (1993) HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res. 603, 222-233.
14. Insel T. R., Miller L. P. and Gelhard R. E. (1990) The ontogeny of excitatory amino acid receptors in rat forebrain - I. N-Methyl-D-aspartate and quisqualate receptors. Neuroscience 35, 31-43.
15. Kimes A. S., London E. D., Szabo G., Raymon L. and Tabakoff B. (1991) Reduction of cerebral glucose utilization by the HIV envelope glycoprotein gp-120. Expl Neurol. 112, 224-228.
16. Koka P., He K. Y., Zack J. A., Kitchen S., Peacock W., Fried I., Tran T., Yashar S. S. and Merrill J. E. (1995) Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor α, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J. exp. Med. 182, 941-951.
17. Konigsmark B. W. (1970) Methods for the counting of neurons. In Contemporary Research Methods in Neuroanatomy (eds Nauta W. J. H. and Ebbesson S. O. E.), pp. 315-340. Springer, New York.
18. Lipton S. A. (1992) Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci. 15, 75-79.
19. Lipton S. A. (1992) Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. NeuroReport 3, 913-915.
20. Lipton S. A. (1992) Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 42, 1403-1405.
21. Lipton S. A., Brenneman D. E., Silverstein F. S., Masliah E. and Mucke L. (1995) Gp120 and neurotoxicity in vivo. Trends pharmac. Sci. 16, 122.
22. Lipton S. A., Sucher N. J., Kaiser P. K. and Dreyer E. B. (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7, 111-118.
23. Lipton S. A., Yeh M. and Dreyer E. B. (1994) Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide. Adv. Neuroimmun. 4, 181-188.
24. Lo T. M., Fallert C. J., Piser T. M. and Thayer S. A. (1992) HIV-1 envelope protein evokes intracellular calcium oscillations in rat hippocampal neurons. Brain Res. 594, 189-196.
25. Maragos W. F. and Silverstein F. S. (1995) The mitochondrial inhibitor malonate enhances NMDA toxicity in the neonatal rat striatum. Devl Brain Res. 88, 117-121.
26. Masliah E., Achim C. L., Ge N. F., Deteresa R., Terry R. D. and Wiley C. A. (1992) Spectrum of human immunodeficiency virus associated neocortical damage. Ann. Neurol. 32, 321-329.
27. Masliah E., Ge N., Morey M., Deteresa R., Terry R. D. and Wiley C. A. (1992) Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab. Invest. 66, 285-291.
28. McDonald J. W., Chen C. K., Trescher W. H. and Johnston M. V. (1991) The severity of excitotoxic brain injury is dependent on brain temperature in immature rat. Neurosci. Lett. 126, 83-86.
29. McDonald J. W., Johnston M. V. and Young A. B. (1990) Differential ontogenic development of three receptors comprising the NMDA receptor/channel complex in the rat hippocampus. Expl Neurol. 110, 237-247.
30. McDonald J. W., Roeser N. F., Silverstein F. S. and Johnston M. V. (1989) Quantitative assessment of neuroprotection against NMDA-induced brain injury. Expl Neurol. 106, 289-296.
31. McDonald J. W., Silverstein F. S., Cardona D., Hudson C., Chen R. and Johnston M. V. (1990) Systemic administration of MK-801 protects against N-methyl-D-aspartate-and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience 36, 589-599.
32. McDonald J. W., Silverstein F. S. and Johnston M. V. (1988) Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res. 459, 200-203.
33. McDonald J. W., Silverstein F. S. and Johnston M. V. (1989) Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model. Brain Res. 490, 33-40.
34. McDonald J. W., Trescher W. H. and Johnston M. V. (1992) Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development. Brain Res. 583, 54-70.
35. McDonald J. W., Uckele J., Silverstein F. S. and Johnston M. V. (1989) HA-966 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces N-methyl-D-aspartate (NMDA)-mediated brain damage. Neurosci. Lett. 104, 167-170.
36. Merrill J. E., Koyanagi Y., Zack J., Thomas L., Martin F. and Chen I. S. Y. (1992) Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type-1. J. Virol. 66, 2217-2225.
37. Muller W. E. G., Schroder H. C., Ushijima H., Dapper J. and Bormann J. (1992) Gp120 of HIV-1 induces apoptosis in rat cortical cell cultures - prevention by memantine. Eur. J. Pharmac. molec. Pharmac. 226, 209-214.
38. Nair M. P., Pottathil R., Heimer E. P. and Schwartz S. A. (1988) Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc. natn. Acad. Sci. U.S.A. 85, 6498-6502.
39. Nelson C. and Silverstein F. S. (1994) Acute disruption of cytochrome oxidase activity in brain in a perinatal rat stroke model. Pediatr. Res. 36, 12-19.
40. Novelli A., Reilly J. A., Lysko P. G. and Henneberry R. C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451, 205-212.
41. Pietraforte D., Tritarelli E., Testa U. and Minetti M. (1994) Gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J. Leukocyte Biol. 55, 175-182.
42. Pittaluga A. and Raiteri M. (1994) HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings. Eur. J. Neurosci. 6, 1743-1749.
43. Price R. H., Hollingsworth Z., Young A. B. and Penney J. B. (1993) Excitatory amino acid receptor regulation after subthalamic nucleus lesions in the rat. Brain Res. 602, 157-160.
44. Silverstein F. S., Barks J. D. E. and Sun R. (1993) GP120, an HIV-1 derived peptide, selectively augments NMDA-mediated hippocampal injury in perinatal rodents. Soc. Neurosci. Abstr. 19, 1772.
45. Silverstein F. S., Chen R. and Johnston M. V. (1986) The glutamate analogue quisqualic acid is neurotoxic in striatum and hippocampus of immature rat brain. Neurosci. Lett. 71, 13-18.
46. Silverstein F. S., Naik B. and Simpson J. (1991) Hypoxia-ischemia stimulates hippocampal glutamate efflux in perinatal rat brain - an in vivo microdialysis study. Pediatr. Res. 30, 587-590.
47. Silverstein F. S., Simpson J. and Gordon K. E. (1990) Hypoglycemia alters striatal amino acid efflux in perinatal rats: an in vivo microdialysis study. Ann. Neurol. 28, 516-521.
48. Sundar S. K., Cierpial M. A., Kamaraju L. S., Long S., Hsieh S., Lorenz C. Aaron M., Ritchie J. C. and Weiss J. M. (1991) Human immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin-1 to elevate pituitary adrenal activity and decrease peripheral cellular immune responses. Proc. natn. Acad. Sci. U.S.A. 88, 11246-11250.
49. Tornatore C., Chandra R., Berger J. R. and Major E. O. (1994) HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44, 481-487.
50. Ushijima H., Nishio O., Klöcking R., Perovic S. and Müller W. E. G. (1995) Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity. Eur. J. Neurosci. 7, 1353-1359.
51. Weiss J. M., Zhang Z., Emery M., Lai E., Bonsall R., Kalyanaraman V. S. and Quan N. (1995) Induction of interleukin-1 bioactivity after intracerebral infusion of native gp120 and gp160. Soc. Neurosci. Abstr. 21, 1151.
52. Yeung M. C., Pulliam L. and Lau A. S. (1995) The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-α. AIDS 9, 137-143.